183 related articles for article (PubMed ID: 33839022)
1. A parvalbumin allergy case was successfully treated with oral immunotherapy using hypoallergenic fish.
Ugajin T; Kobayashi Y; Takayama K; Yokozeki H
Allergol Int; 2021 Oct; 70(4):509-511. PubMed ID: 33839022
[No Abstract] [Full Text] [Related]
2. A general strategy for the generation of hypoallergenic molecules for the immunotherapy of fish allergy.
Swoboda I; Balic N; Klug C; Focke M; Weber M; Spitzauer S; Neubauer A; Quirce S; Douladiris N; Papadopoulos NG; Valenta R
J Allergy Clin Immunol; 2013 Oct; 132(4):979-81.e1. PubMed ID: 23763969
[No Abstract] [Full Text] [Related]
3. Selective Allergy to Conger Fish due to Parvalbumin.
Argiz L; Vega F; Castillo M; Pineda F; Blanco C
J Investig Allergol Clin Immunol; 2019; 29(5):390-391. PubMed ID: 31062690
[No Abstract] [Full Text] [Related]
4. A recombinant hypoallergenic parvalbumin mutant for immunotherapy of IgE-mediated fish allergy.
Swoboda I; Bugajska-Schretter A; Linhart B; Verdino P; Keller W; Schulmeister U; Sperr WR; Valent P; Peltre G; Quirce S; Douladiris N; Papadopoulos NG; Valenta R; Spitzauer S
J Immunol; 2007 May; 178(10):6290-6. PubMed ID: 17475857
[TBL] [Abstract][Full Text] [Related]
5. Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy.
Zuidmeer-Jongejan L; Huber H; Swoboda I; Rigby N; Versteeg SA; Jensen BM; Quaak S; Akkerdaas JH; Blom L; Asturias J; Bindslev-Jensen C; Bernardi ML; Clausen M; Ferrara R; Hauer M; Heyse J; Kopp S; Kowalski ML; Lewandowska-Polak A; Linhart B; Maderegger B; Maillere B; Mari A; Martinez A; Mills EN; Neubauer A; Nicoletti C; Papadopoulos NG; Portoles A; Ranta-Panula V; Santos-Magadan S; Schnoor HJ; Sigurdardottir ST; Stahl-Skov P; Stavroulakis G; Stegfellner G; Vázquez-Cortés S; Witten M; Stolz F; Poulsen LK; Fernandez-Rivas M; Valenta R; van Ree R
Int Arch Allergy Immunol; 2015; 166(1):41-51. PubMed ID: 25765512
[TBL] [Abstract][Full Text] [Related]
6. In vivo allergenic activity of a hypoallergenic mutant of the major fish allergen Cyp c 1 evaluated by means of skin testing.
Douladiris N; Linhart B; Swoboda I; Gstöttner A; Vassilopoulou E; Stolz F; Valenta R; Papadopoulos NG
J Allergy Clin Immunol; 2015 Aug; 136(2):493-5.e8. PubMed ID: 25746971
[No Abstract] [Full Text] [Related]
7. Does clinical protection persist after food allergen oral immunotherapy?
Vickery BP
Immunotherapy; 2015; 7(8):851-3. PubMed ID: 26314347
[No Abstract] [Full Text] [Related]
8. Oral Immunotherapy to Hake in 8 Pediatric Patients.
Martorell-Calatayud C; Carnés J; Michavila Gómez A; Dopazo Fernández L; Echeverría Zudaire L; Santana Rodríguez C; Gómez Galán C; Toral Pérez T; Rodríguez Del Río P; Martorell Aragonés A
J Investig Allergol Clin Immunol; 2019 Aug; 29(4):294-296. PubMed ID: 31478523
[No Abstract] [Full Text] [Related]
9. Oral Immunotherapy: An Overview.
Todoric K; Merrill S
Med Clin North Am; 2024 Jul; 108(4):719-731. PubMed ID: 38816113
[TBL] [Abstract][Full Text] [Related]
10. Blocking antibodies induced by immunization with a hypoallergenic parvalbumin mutant reduce allergic symptoms in a mouse model of fish allergy.
Freidl R; Gstoettner A; Baranyi U; Swoboda I; Stolz F; Focke-Tejkl M; Wekerle T; van Ree R; Valenta R; Linhart B
J Allergy Clin Immunol; 2017 Jun; 139(6):1897-1905.e1. PubMed ID: 27876628
[TBL] [Abstract][Full Text] [Related]
11. Sublingual vs oral immunotherapy for food allergy: identifying the right approach.
Narisety SD; Keet CA
Drugs; 2012 Oct; 72(15):1977-89. PubMed ID: 23009174
[TBL] [Abstract][Full Text] [Related]
12. Epicutaneous immunotherapy: the next step for food allergy desensitization.
De Jong NW
Expert Rev Clin Immunol; 2018 Dec; 14(12):977-978. PubMed ID: 30295101
[No Abstract] [Full Text] [Related]
13. A new approach to oral allergen immunotherapy for food allergy?
Roberts G
Clin Exp Allergy; 2018 Jul; 48(7):758-759. PubMed ID: 29947140
[No Abstract] [Full Text] [Related]
14. Recent advances in immunotherapy: the active treatment of food allergy on the horizon.
Pajno GB; Caminiti L; Crisafulli G; Salzano G
Expert Rev Clin Immunol; 2013 Oct; 9(10):891-3. PubMed ID: 24128153
[No Abstract] [Full Text] [Related]
15. Targeting IgE to facilitate oral immunotherapy for food allergy: a potential new role for anti-IgE therapy?
Umetsu DT
Expert Rev Clin Immunol; 2014 Sep; 10(9):1125-8. PubMed ID: 25119422
[TBL] [Abstract][Full Text] [Related]
16. [New therapeutic approaches to food allergies].
Dupont C
Arch Pediatr; 2014 Jun; 21(6):564-6. PubMed ID: 24768549
[No Abstract] [Full Text] [Related]
17. Apple desensitization in two patients with PR-10 proteins allergy.
Nucera E; Aruanno A; Lombardo C; Patriarca G; Schiavino D
Allergy; 2010 Aug; 65(8):1060-1. PubMed ID: 19958318
[No Abstract] [Full Text] [Related]
18. Pioneering immunotherapy for food allergy: clinical outcomes and modulation of the immune response.
Kulis M; Vickery BP; Burks AW
Immunol Res; 2011 Apr; 49(1-3):216-26. PubMed ID: 21161431
[TBL] [Abstract][Full Text] [Related]
19. Current and Emerging Therapies for IgE-Mediated Food Allergy.
Pesek RD; Jones SM
Curr Allergy Asthma Rep; 2016 Apr; 16(4):28. PubMed ID: 26942731
[TBL] [Abstract][Full Text] [Related]
20. Food Allergy Immunotherapy with Adjuvants.
Nicolaides RE; Parrish CP; Bird JA
Immunol Allergy Clin North Am; 2020 Feb; 40(1):149-173. PubMed ID: 31761115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
